0001178913-26-001908.txt : 20260330 0001178913-26-001908.hdr.sgml : 20260330 20260330183506 ACCESSION NUMBER: 0001178913-26-001908 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20260318 FILED AS OF DATE: 20260330 DATE AS OF CHANGE: 20260330 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Geva Harel Lilach CENTRAL INDEX KEY: 0002115658 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-13742 FILM NUMBER: 26815728 MAIL ADDRESS: ADDRESS IS A NON US LOCATION: YES STREET 1: 23 ARANHA ST. CITY: TEL AVIV PROVINCE COUNTRY: L3 ZIP: 6120201 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ICL Group Ltd. CENTRAL INDEX KEY: 0000941221 STANDARD INDUSTRIAL CLASSIFICATION: AGRICULTURE CHEMICALS [2870] ORGANIZATION NAME: 08 Industrial Applications and Services EIN: 000000000 STATE OF INCORPORATION: L3 FISCAL YEAR END: 1231 BUSINESS ADDRESS: ADDRESS IS A NON US LOCATION: YES STREET 1: MILLENNIUM TOWER STREET 2: 23 ARANHA STREET, P.O. BOX 20245 CITY: TEL AVIV PROVINCE COUNTRY: L3 BUSINESS PHONE: (972-3) 684-4400 MAIL ADDRESS: ADDRESS IS A NON US LOCATION: YES STREET 1: MILLENNIUM TOWER STREET 2: 23 ARANHA STREET, P.O. BOX 20245 CITY: TEL AVIV PROVINCE COUNTRY: L3 FORMER COMPANY: FORMER CONFORMED NAME: ISRAEL CHEMICALS LTD DATE OF NAME CHANGE: 19950314 3 1 ownership.xml X0607 3 2026-03-18 0 0000941221 ICL Group Ltd. ICL ICL 0002115658 Geva Harel Lilach true C/O ICL GROUP LTD. MILLENNIUM TOWER, 23 ARENHA ST. TEL AVIV L3 6120201 ISRAEL 0 1 0 0 Deputy Chief Executive Officer Stock Options (Right to Buy) 9.39 2027-02-08 Ordinary Shares 649180 D Stock Options (Right to Buy) 5.87 2029-04-04 Ordinary Shares 984095 D Stock Options (Right to Buy) 5.91 2030-12-07 Ordinary Shares 416667 D The stock options are fully vested and exercisable. The stock options vest in three equal annual installments from the April 4, 2024, grant date. The stock options vest in three equal annual installments from the December 7, 2025, grant date. Represents an exercise price of NIS 29.57, converted to U.S. dollars using the Bank of Israel representative exchange rate of $1.00 to NIS 3.149 as of March 27, 2026. The options are held by a Trustee in the name of the Reporting Person. Represents an exercise price of NIS 18.47, converted to U.S. dollars using the Bank of Israel representative exchange rate of $1.00 to NIS 3.149 as of March 27, 2026. Represents an exercise price of NIS 18.60, converted to U.S. dollars using the Bank of Israel representative exchange rate of $1.00 to NIS 3.149 as of March 27, 2026. /s/ Geva Harel Lilach 2026-03-30